ITMCTR2200006853招募中1 期
medicine
Jiangsu Integrated Traditional Chinese and Western Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- All
入选标准
- •(1) Meet the diagnostic criteria of RA and the syndrome differentiation criteria of TCM bi syndrome (phlegm and blood stasis bi); (2) The age ranged from 18 to 65; (3) Did not receive slow-acting anti-rheumatism drugs within 3 months before the study began; (4) No non-steroidal anti-inflammatory drugs, hormones or other drugs were taken within 2 weeks before the study; (5) Sign informed consent voluntarily.
排除标准
- •(1) Lung interstitial disease; (2) With other connective tissue diseases; (3) Liver and kidney dysfunction (AST/ALT and SCr exceeding the normal upper limit); (4) Uncontrolled hypertension grade 2 and above; (5) Uncontrolled diabetes, or combined with diabetic target organ damage; (6) Previous history of gastrointestinal ulcer; Combined with serious cardiovascular and cerebrovascular diseases, blood, malignant tumors and other serious diseases; (8) Chronic infectious diseases, including hepatitis, tuberculosis, etc. (9) Patients who are participating in other clinical studies; (10) Male patients with fertility plans within six months, female patients with fertility plans, and patients during pregnancy and lactation; Suspected or proven history of alcohol or drug abuse or, in the investigator's judgment, likely to reduce or complicate enrollment
研究者
相似试验
尚未招募
1 期
Clinical application ofCOVID-19ITMCTR2200006066Shanghai Tenth People's Hospital
招募中
1 期
Feasibility and tolerability of 28 days intravaginal oxybutynin via the MedRing OAB systemCTIS2023-508692-36-00iGalli B.V.12
进行中(未招募)
1 期
.EUCTR2018-003565-33-FRCHU de Clermont-Ferrand120
进行中(未招募)
1 期
.EUCTR2016-001341-41-FRCHU de Clermont-Ferrand
进行中(未招募)
不适用
.EUCTR2014-001452-28-FRCHU de Clermont-Ferrand
